Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ann Folkins"'
Hemophagocytic lymphohistiocytosis as a paraneoplastic syndrome associated with ovarian dysgerminoma
Publikováno v:
Gynecologic Oncology Reports, Vol 17, Iss C, Pp 38-41 (2016)
Externí odkaz:
https://doaj.org/article/8d31d7ce049e4d99a3b0e51d09c7f1be
Autor:
Rebecca Rojansky, Iny Jhun, Alex M. Dussaq, Steven M. Chirieleison, Jeffrey J. Nirschl, Don Born, Jennifer Fralick, William Hetherington, Alison M. Kerr, Jonathan Lavezo, Daniel B. Lawrence, Seth Lummus, Ronald Macasaet, Thomas J. Montine, Emily Ryan, Jeanne Shen, Jonathan Shoemaker, Brent Tan, Hannes Vogel, Puneet Singh Waraich, Eric Yang, April Young, Ann Folkins
Publikováno v:
Arch Pathol Lab Med
Context.— Stanford Pathology began stepwise subspecialty implementation of whole slide imaging (WSI) in 2018 soon after the first US Food and Drug Administration approval. In 2020, during the COVID-19 pandemic, the Centers for Medicare & Medicaid S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e507e276f7b6aca023e16d3027de6559
https://europepmc.org/articles/PMC9904534/
https://europepmc.org/articles/PMC9904534/
Autor:
Emily E. Ryan, Nivaz Brar, Grace Allard, Aihui Wang, Virginia D. Winn, Ann Folkins, Eric J. Yang, Serena Tan, Florette K. Hazard, Brooke E. Howitt
Publikováno v:
International Journal of Gynecological Pathology.
Autor:
Ann, Folkins, Lilliam, Cruz, Donald P, Goldstein, Ross S, Berkowitz, Christopher, Crum, David, Kindelberger
Publikováno v:
The Journal of reproductive medicine. 55(7-8)
The introduction of p57 immunohistochemistry has aided the distinction between early complete moles (CMs) and hydropic abortus (HA), but no single technique has emerged for the distinction between early partial moles (PMs) and HA. Flow cytometry and
Autor:
Yueju Li, K B S Ann Folkins, Primo N. Lara, Laurel A. Beckett, Regina Gandour-Edwards, Ralph DeVere-White, Janine M. LaSalle, Frederick J. Meyers
Publikováno v:
Cancer. 95(5)
BACKGROUND Muscle-invasive urothelial carcinoma of the bladder is a highly lethal malignancy, particularly in the setting of locally advanced or metastatic disease. Prior reports of HER2/neu (c-erbB-2 or HER2) expression in bladder carcinoma have bee